Physician profile
Wei Huang
NPI 1508001876
$5,884.48
in general payments reported to CMS, 2019-2025
15 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,777 · 2020: $265 · 2021: $504 · 2022: $476 · 2023: $752 · 2024: $430 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,863.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,261.47 | 2019-2023 | Tecnis Iol |
| Alcon Vision LLC | $2,177.49 | 2019-2025 | Clareon, Clareon Panoptix Pro, Lensx |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $356.35 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $223.33 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $190.79 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $148.55 | 2025 | |
| New World Medical,INC. | $119.25 | 2019 | |
| Amgen INC. | $109.04 | 2024 | Tepezza |
| Sight Sciences, INC. | $85.15 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Horizon Therapeutics Plc | $64.76 | 2023 | Tepezza |
| Glaukos Corporation | $39.66 | 2019-2022 | |
| Allergan, INC. | $32.39 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $31.40 | 2020-2025 | |
| Rayner Intraocular Lenses Limited | $31.39 | 2025 | Omidria |
| Tarsus Pharmaceuticals, INC. | $13.46 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.